Sudden Cardiac Death Medication

1. Berdowski J, Blom MT, Bardai A, Tan HL, Tijssen JG, Koster RW. Impact of Onsite or Dispatched Automated External Defibrillator Use on Survival After Out-of-Hospital Cardiac Arrest. Circulation. 2011 Nov 15. 124(20):2225-32. [QxMD MEDLINE Link].

2. Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004 Jan. 8;350(2):105-13. [QxMD MEDLINE Link].

3. Holzer M. Targeted temperature management for comatose survivors of cardiac arrest. N Engl J Med. 2010 Sep 23. 363(13):1256-64. [QxMD MEDLINE Link].

4. Ezekowitz JA, Rowe BH, Dryden DM, et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007 Aug. 21;147(4):251-62. [QxMD MEDLINE Link].

5. Shen L, Jhund PS, Anand IS, et al. Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction. Clin Res Cardiol. 2020 Dec 10. [QxMD MEDLINE Link].

6. Ikeda Y, Yutani C, Huang Y, et al. Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy. Cardiovasc Pathol. 2001 Jan-Feb. 10(1):19-27. [QxMD MEDLINE Link].

7. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000 Jan. 35(1):36-44. [QxMD MEDLINE Link].

8. Brooks A, Schinde V, Bateman AC, Gallagher PJ. Interstitial fibrosis in the dilated non-ischaemic myocardium. Heart. 2003 Oct. 89(10):1255-6. [QxMD MEDLINE Link].

9. Fielitz J, Hein S, Mitrovic V, et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol. 2001 Apr. 37(5):1443-9. [QxMD MEDLINE Link].

10. Sovari AA, Cesario D, Kocheril AG, Brugada R. Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm. J Interv Card Electrophysiol. 2008 Apr. 21(3):223-6. [QxMD MEDLINE Link].

11. Chizner MA, Pearle DL, deLeon AC. The natural history of aortic stenosis in adults. Am Heart J. 1980 Apr. 99(4):419-24. [QxMD MEDLINE Link].

12. Haïssaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008 May 8. 358(19):2016-23. [QxMD MEDLINE Link].

13. Derval N, Simpson CS, Birnie DH, et al. Prevalence and Characteristics of Early Repolarization in the CASPER Registry Cardiac Arrest Survivors With Preserved Ejection Fraction Registry. J Am Coll Cardiol. 2011 Aug 9. 58(7):722-8. [QxMD MEDLINE Link].

14. Gollob MH, Redpath CJ, Roberts JD. The Short QT Syndrome Proposed Diagnostic Criteria. J Am Coll Cardiol. 2011 Feb 15. 57(7):802-12. [QxMD MEDLINE Link].

15. Giustetto C, Schimpf R, Mazzanti A, et al. Long-Term Follow-Up of Patients With Short QT Syndrome. J Am Coll Cardiol. 2011 Aug 2. 58(6):587-95. [QxMD MEDLINE Link].

16. Delise P, Allocca G, Marras E, et al. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J. 2011 Jan. 32(2):169-76. [QxMD MEDLINE Link].

17. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009 Apr. 15(4):380-3. [QxMD MEDLINE Link].

18. Mehra R. Global public health problem of sudden cardiac death. Journal of Electrocardiology. 2007 Nov-Dec. 40(6 Suppl):S118-22. [QxMD MEDLINE Link].

19. Gillum RF. Sudden coronary death in the United States: 1980-1985. Circulation. 1989 Apr. 79(4):756-65. [QxMD MEDLINE Link].

20. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J. 1987 Mar. 113(3):799-804. [QxMD MEDLINE Link].

21. Kuller LH. Sudden death--definition and epidemiologic considerations. Prog Cardiovasc Dis. 1980 Jul-Aug. 23(1):1-12. [QxMD MEDLINE Link].

22. Thompson RJ, McCullough PA, Kahn JK. Prediction of death and neurologic outcome in the emergency department in out-of-hospital cardiac arrest survivors. Am J Cardiol. 1998 Jan 1. 81(1):17-21. [QxMD MEDLINE Link].

23. Thompson RJ, McCullough PA, Kahn JK. Early prediction of death and neurologic outcome in out-of-hospital sudden death survivors in the emergency department. Circulation. 1996. 94:I-356.

24. McCullough PA, Thompson RJ, Tobin KJ. Validation of a decision support tool for the evaluation of cardiac arrest victims. Clin Cardiol. 1998 Mar. 21(3):195-200. [QxMD MEDLINE Link].

25. Merchant FM, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Chow T, Chan PS, et al. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. Heart Rhythm. 2012 Aug. 9(8):1256-1264.e2. [QxMD MEDLINE Link]. [Full Text].

26. Bobrow BJ, Spaite DW, Berg RA, Stolz U, Sanders AB, Kern KB. Chest compression-only CPR by lay rescuers and survival from out-of-hospital cardiac arrest. JAMA. 2010 Oct 6. 304(13):1447-54. [QxMD MEDLINE Link].

27. Delhomme C, Njeim M, Varlet E, et al. Automated external defibrillator use in out-of-hospital cardiac arrest: Current limitations and solutions. Arch Cardiovasc Dis. 2019 Mar. 112 (3):217-22. [QxMD MEDLINE Link].

28. Adielsson A, Hollenberg J, Karlsson T, et al. Increase in survival and bystander CPR in out-of-hospital shockable arrhythmia: bystander CPR and female gender are predictors of improved outcome. Experiences from Sweden in an 18-year perspective. Heart. 2011 Sep. 97(17):1391-6. [QxMD MEDLINE Link].

29. Kuriachan VP, Sumner GL, Mitchell LB. Sudden cardiac death. Curr Probl Cardiol. 2015 Apr. 40 (4):133-200. [QxMD MEDLINE Link].

30. Dumas F, Grimaldi D, Zuber B, et al. Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation. 2011 Mar 1. 123(8):877-86. [QxMD MEDLINE Link].

31. Yousuf O, Chrispin J, Tomaselli GF, Berger RD. Clinical management and prevention of sudden cardiac death. Circ Res. 2015 Jun 5. 116 (12):2020-40. [QxMD MEDLINE Link].

32. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996 Dec. 26;335(26):1933-40. [QxMD MEDLINE Link].

33. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar. 21;346(12):877-83. [QxMD MEDLINE Link].

34. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004 May. 20;350(21):2151-8. [QxMD MEDLINE Link].

35. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan. 20;352(3):225-37. [QxMD MEDLINE Link].

36. Bardy GH, Lee KL, Mark DB, et al. Home Use of Automated ExternalDefibrillators for Sudden Cardiac Arrest. N Engl J Med. 2008 Apr. 24;358(17):1793-804. [QxMD MEDLINE Link].

37. Kwon OY. The changes in cardiopulmonary resuscitation guidelines: from 2000 to the present. J Exerc Rehabil. 2019 Dec. 15 (6):738-46. [QxMD MEDLINE Link]. [Full Text].

38. [Guideline] Link MS, Berkow LC, Kudenchuk PJ, Halperin HR, Hess EP, Moitra VK, et al. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015 Nov 3. 132 (18 Suppl 2):S444-64. [QxMD MEDLINE Link]. [Full Text].

39. [Guideline] Soar J, Callaway CW, Aibiki M, et al. Part 4: Advanced life support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation. 2015 Oct. 95:e71-120. [QxMD MEDLINE Link]. [Full Text].

40. [Guideline] Soar J, Nolan JP, Böttiger BW, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. Resuscitation. 2015 Oct. 95:100-47. [QxMD MEDLINE Link]. [Full Text].

41. [Guideline] Neumar RW, Barnhart JM, Berg RA, et al. Implementation Strategies for Improving Survival After Out-of-Hospital Cardiac Arrest in the United States: Consensus Recommendations From the 2009 American Heart Association Cardiac Arrest Survival Summit. Circulation. 2011 Jun 21. 123(24):2898-2910. [QxMD MEDLINE Link]. [Full Text].

42. [Guideline] Piccini JP Sr, Allen LA, Kudenchuk PJ, Page RL, Patel MR, Turakhia MP, et al. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association. Circulation. 2016 Apr 26. 133 (17):1715-27. [QxMD MEDLINE Link]. [Full Text].

43. [Guideline] Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013 Dec. 10 (12):1932-63. [QxMD MEDLINE Link]. [Full Text].

44. Altemose GT, Buxton AE. Idiopathic ventricular tachycardia. Annu Rev Med. 1999. 50:159-77. [QxMD MEDLINE Link].

45. Anderson KP, Freedman RA, Mason JW. Sudden death in idiopathic dilated cardiomyopathy. Ann Intern Med. 1987 Jul. 107(1):104-6. [QxMD MEDLINE Link].

46. Antiarrhythmics Versus Implantable Defibrillators Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997 Nov 27. 337(22):1576-83. [QxMD MEDLINE Link].

47. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989 Jan. 117(1):151-9. [QxMD MEDLINE Link].

48. Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol. 1993 Jun. 4(3):356-68. [QxMD MEDLINE Link].

49. Benditt DG, Pritchett LC, Smith WM, et al. Characteristics of atrioventricular conduction and the spectrum of arrhythmias in Lown-Ganong-Levine syndrome. Circulation. 1978 Mar. 57(3):454-65. [QxMD MEDLINE Link].

50. Berger S, Dhala A, Friedberg DZ. Sudden cardiac death in infants, children, and adolescents. Pediatr Clin North Am. 1999 Apr. 46(2):221-34. [QxMD MEDLINE Link].

51. Beta-blocker Heart Attack Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982 Mar 26. 247(12):1707-14. [QxMD MEDLINE Link].

52. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997 Nov 27. 337(22):1569-75. [QxMD MEDLINE Link].

53. Bigger JT, Fleiss JL, Kleiger R. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984 Feb. 69(2):250-8. [QxMD MEDLINE Link].

54. Blackstone EH, Kirklin JW. Death and other time-related events after valve replacement. Circulation. 1985 Oct. 72(4):753-67. [QxMD MEDLINE Link].

55. Bromberg BI, Lindsay BD, Cain ME. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1996 Mar 1. 27(3):690-5. [QxMD MEDLINE Link].

56. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998 Feb 10. 97(5):457-60. [QxMD MEDLINE Link].

57. Brugada P, Brugada J. A distinct clinical and echocardiographic syndrome: right bundle branch block, persistent ST segment elevation with normal QT interval and sudden cardiac death. PACE. 1991. 14:746-51.

58. Brugada R, Hong K, Cordeiro JM. Short QT syndrome. CMAJ. 2005. 173(11):1349-54.

59. Burkart F, Pfisterer M, Kiowski W. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol. 1990 Dec. 16(7):1711-8. [QxMD MEDLINE Link].

60. Burke AP, Farb A, Malcom GT. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997 May 1. 336(18):1276-82. [QxMD MEDLINE Link].

61. Cairns JA, Connolly SJ, Roberts R. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997 Mar 8. 349(9053):675-82. [QxMD MEDLINE Link].

62. Cardiac Arrhythmia Suppression Trial Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med. 1989 Aug 10. 321(6):406-12. [QxMD MEDLINE Link].

63. Chang D, Goldstein S. Sudden cardiac death in ischemic heart disease. Compr Ther. 1997 Feb. 23(2):95-103. [QxMD MEDLINE Link].

64. Corrado D, Basso C, Thiene G. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997 Nov 15. 30(6):1512-20. [QxMD MEDLINE Link].

65. Davies MJ. The investigation of sudden cardiac death. Histopathology. 1999 Feb. 34(2):93-8. [QxMD MEDLINE Link].

66. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984 May 3. 310(18):1137-40. [QxMD MEDLINE Link].

67. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van Ree JW, Daemen MJ, Houben LG, et al. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol. 1997 Nov 15. 30(6):1500-5. [QxMD MEDLINE Link].

68. DeRose JJ, Banas JS, Winters SL. Current perspectives on sudden cardiac death in hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 1994 May-Jun. 36(6):475-84. [QxMD MEDLINE Link].

69. Domanski MJ, Zipes DP, Schron E. Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions. Circulation. 1997 Jun 17. 95(12):2694-9. [QxMD MEDLINE Link].

70. Doval HC, Nul DR, Grancelli HO. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA- GEMA Investigators. Circulation. 1996 Dec 15. 94(12):3198-203. [QxMD MEDLINE Link].

71. Doyle JT, Kannel WB, McNamara PM. Factors related to suddenness of death from coronary disease: combined Albany-Framingham studies. Am J Cardiol. 1976 Jun. 37(7):1073-8. [QxMD MEDLINE Link].

72. Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol. 1985 Jun. 5(6 Suppl):118B-121B. [QxMD MEDLINE Link].

73. Echt DS, Liebson PR, Mitchell LB. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21. 324(12):781-8. [QxMD MEDLINE Link].

74. Ehtisham J, Watkins H. Is Wolff-Parkinson-White syndrome a genetic disease?. J Cardiovasc Electrophysiol. 2005. 16(11):1258-62.

75. Garson A, McNamara DG. Sudden death in a pediatric cardiology population, 1958 to 1983: relation to prior arrhythmias. J Am Coll Cardiol. 1985 Jun. 5(6 Suppl):134B-137B. [QxMD MEDLINE Link].

76. Gillum RF. Coronary heart disease in black populations. I. Mortality and morbidity. Am Heart J. 1982 Oct. 104(4 Pt 1):839-51. [QxMD MEDLINE Link].

77. Gilman JK, Jalal S, Naccarelli GV. Predicting and preventing sudden death from cardiac causes. Circulation. 1994 Aug. 90(2):1083-92. [QxMD MEDLINE Link].

78. Goldberger JJ. Treatment and prevention of sudden cardiac death: effect of recent clinical trials. Arch Intern Med. 1999 Jun 28. 159(12):1281-7. [QxMD MEDLINE Link].

79. Goldstein S. The necessity of a uniform definition of sudden coronary death: witnessed death within 1 hour of the onset of acute symptoms. Am Heart J. 1982 Jan. 103(1):156-9. [QxMD MEDLINE Link].

80. Goldstein S, Landis JR, Leighton R. Characteristics of the resuscitated out-of-hospital cardiac arrest victim with coronary heart disease. Circulation. 1981 Nov. 64(5):977-84. [QxMD MEDLINE Link].

81. Gottlieb SS. The use of antiarrhythmic agents in heart failure: implications of CAST. Am Heart J. 1989 Nov. 118(5 Pt 1):1074-7. [QxMD MEDLINE Link].

82. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013 Mar 6. 309(9):896-908. [QxMD MEDLINE Link].

83. Holmes DR, Davis KB, Mock MB. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation. 1986 Jun. 73(6):1254-63. [QxMD MEDLINE Link].

84. Iseri LT, Humphrey SB, Siner EJ. Prehospital brady-asystolic cardiac arrest. Ann Intern Med. 1978 Jun. 88(6):741-5. [QxMD MEDLINE Link].

85. Itoh H, Horie M, Ito M. Arrhythmogenesis in the short-QT syndrome associated with combined HERG channel gating defects: a simulation study. Circ J. 2006. 70(4):502-8.

86. Jaoude SA, Leclercq JF, Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. Eur Heart J. 1996 Nov. 17(11):1717-22. [QxMD MEDLINE Link].

87. Kunavarapu C, Bloomfield DM. Role of noninvasive studies in risk stratification for sudden cardiac death. Clin Cardiol. 2004. 27(4):192-7.

88. Ladich E, Virmani R, Burke A. Sudden cardiac death not related to coronary atherosclerosis. Toxicol Pathol. 2006. 34(1):52-7.

89. Latini R, Maggioni AP, Flather M. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation. 1995 Nov 15. 92(10):3132-7. [QxMD MEDLINE Link].

90. Lerman BB, Stein KM, Markowitz SM. Idiopathic right ventricular outflow tract tachycardia: a clinical approach. Pacing Clin Electrophysiol. 1996 Dec. 19(12 Pt 1):2120-37. [QxMD MEDLINE Link].

91. Lombardi G, Gallagher J, Gennis P. Outcome of out-of-hospital cardiac arrest in New York City. The Pre- Hospital Arrest Survival Evaluation (PHASE) Study. JAMA. 1994 Mar 2. 271(9):678-83. [QxMD MEDLINE Link].

92. Makikallio TH, Barthel P, Schneider R. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol. 2006. 15;97(4):480-4.

93. Marcus FI, Fontaine GH, Guiraudon G. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982 Feb. 65(2):384-98. [QxMD MEDLINE Link].

94. Maron BJ, Bonow RO, Cannon RO. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med. 1987 Apr 2. 316(14):844-52. [QxMD MEDLINE Link].

95. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol. 1986 Jan. 7(1):204-14. [QxMD MEDLINE Link].

96. Maron BJ, Shirani J, Poliac LC. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996 Jul 17. 276(3):199-204. [QxMD MEDLINE Link].

97. Maseri A, Severi S, Marzullo P. Role of coronary arterial spasm in sudden coronary ischemic death. Ann N Y Acad Sci. 1982. 382:204-17. [QxMD MEDLINE Link].

98. Metoprolol in Acute Myocardial Infarction Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo- controlled international trial. The MIAMI Trial Research Group. Eur Heart J. 1985 Mar. 6(3):199-226. [QxMD MEDLINE Link].

99. Moss AJ. Prognosis after myocardial infarction. Am J Cardiol. 1983 Oct 1. 52(7):667-9. [QxMD MEDLINE Link].

100. Moss AJ, Schwartz PJ, Crampton RS. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991 Sep. 84(3):1136-44. [QxMD MEDLINE Link].

101. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Brunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 4th ed. Philadelphia, Pa: WB Saunders; 1992:. 756-89.

102. Myerburg RJ, Estes D, Zaman L. Outcome of resuscitation from bradyarrhythmic or asystolic prehospital cardiac arrest. J Am Coll Cardiol. 1984 Dec. 4(6):1118-22. [QxMD MEDLINE Link].

103. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 1992 Jan. 85(1 Suppl):I2-10. [QxMD MEDLINE Link].

104. Nademanee K, Singh BN, Stevenson WG. Amiodarone and post-MI patients. Circulation. 1993 Aug. 88(2):764-74. [QxMD MEDLINE Link].

105. Napolitano C, Bloise R, Priori SG. Long QT syndrome and short QT syndrome: how to make correct diagnosis and what about eligibility for sports activity. J Cardiovasc Med (Hagerstown). 2006. 7(4):250-6.

106. Narasimhan C, Jazayeri MR, Sra J. Ventricular tachycardia in valvular heart disease: facilitation of sustained bundle-branch reentry by valve surgery. Circulation. 1997 Dec 16. 96(12):4307-13. [QxMD MEDLINE Link].

107. Neuspiel DR, Kuller LH. Sudden and unexpected natural death in childhood and adolescence. JAMA. 1985 Sep 13. 254(10):1321-5. [QxMD MEDLINE Link].

108. Prystowsky EN. Prevention of sudden cardiac death. Clin Cardiol. 2005. 28(11 Suppl 1):I12-8.

109. Rosen MR, Jause MJ, Myerburg RJ. Arrhythmias induced by coronary artery occlusion: what are the electrophysiologic mechanisms? In: Hearse DJ, Mannings AS, Janse M, eds. Life-Threatening Arrhythmias During Ischemia and Infarction. New York, NY: Raven; 1987:. 11-47.

110. Sarkozy A, Brugada P. Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol. 2005. 16 Suppl 1:S8-20.

111. Schoenfeld MH, McGovern B, Garan H. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias. J Am Coll Cardiol. 1985 Aug. 6(2):298-306. [QxMD MEDLINE Link].

112. Spirito P, Seidman CE, McKenna WJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997 Mar 13. 336(11):775-85. [QxMD MEDLINE Link].

113. Sra J, Akhtar M. Recent advances in understanding the mechanisms, diagnosis and treatment of congenital and acquired long QT syndrome. Indian Heart J. 1996 Nov-Dec. 48(6):639-51. [QxMD MEDLINE Link].

114. Stern S, Tzivoni D. Ventricular arrhythmias, sudden death, and silent myocardial ischemia. Prog Cardiovasc Dis. 1992 Jul-Aug. 35(1):19-26. [QxMD MEDLINE Link].

115. Stevenson WG, Stevenson LW, Middlekauff HR. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 1993 Dec. 88(6):2953-61. [QxMD MEDLINE Link].

116. Stiles S. Gd-Enhanced CMR Risk-Stratifies in Ischemics, Nonischemics; Clinical Value Uncertain. Medscape News. Mar 8 2013. Available at http://www.medscape.com/viewarticle/780491. Accessed: Mar 26 2013.

117. Tamburro P, Wilber D. Sudden death in idiopathic dilated cardiomyopathy. Am Heart J. 1992 Oct. 124(4):1035-45. [QxMD MEDLINE Link].

118. Tapanainen JM, Lindgren KS, Makikallio TH. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2004. 43(5):757-63.

119. Viskin S, Lesh MD, Eldar M. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol. 1997 Oct. 8(10):1115-20. [QxMD MEDLINE Link].

120. Watkins H, McKenna WJ, Thierfelder L. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995 Apr 20. 332(16):1058-64. [QxMD MEDLINE Link].

121. Wellens HJ, Durrer D. Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation. Am J Cardiol. 1974 Dec. 34(7):777-82. [QxMD MEDLINE Link].

122. Westenskow P, Splawski I, Timothy KW. Compound mutations: a common cause of severe long-QT syndrome. Circulation. 2004. 109(15):1834-41.

123. Winslow RD, Mehta D, Fuster V. Sudden cardiac death: mechanisms, therapies and challenges. Nat Clin Pract Cardiovasc Med. 2005. 2(7):352-60.

124. Yusuf S, Peto R, Lewis J. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr. 27(5):335-71. [QxMD MEDLINE Link].

125. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998 Nov 24. 98(21):2334-51. [QxMD MEDLINE Link].

126. Bickel T, Gunasekaran P, Murtaza G, Gopinathannair R, Gunda S, Lakkireddy D. Sudden cardiac death in famous athletes, lessons learned, heterogeneity in expert recommendations and pitfalls of contemporary screening strategies. J Atr Fibrillation. 2019 Dec. 12 (4):2193. [QxMD MEDLINE Link]. [Full Text].

127. Merinopoulos I, Corballis N, Eccleshall SC, Vassiliou VS. Risk of sudden cardiac death: Are coronary chronic total occlusions an additional risk factor?. World J Cardiol. 2018 Dec 26. 10 (12):250-3. [QxMD MEDLINE Link]. [Full Text].

Ali A Sovari, MD, FACP, FACC Attending Physician, Cardiac Electrophysiologist, Cedars Sinai Medical Center and St John's Regional Medical Center

Ali A Sovari, MD, FACP, FACC is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Physician Scientists Association, American Physiological Society, Biophysical Society, Heart Rhythm Society, Society for Cardiovascular Magnetic Resonance

Disclosure: Nothing to disclose.

Abraham G Kocheril, MD, FACC, FACP, FHRS Professor of Medicine, University of Illinois College of Medicine

Abraham G Kocheril, MD, FACC, FACP, FHRS is a member of the following medical societies: American College of Cardiology, Central Society for Clinical and Translational Research, Heart Failure Society of America, Cardiac Electrophysiology Society, American College of Physicians, American Heart Association, American Medical Association, Illinois State Medical Society

Disclosure: Nothing to disclose.

Arnold S Baas, MD, FACC, FACP Professor of Medicine, Division of Cardiology, Fellowship Director for Advanced Heart Failure and Transplant Cardiology, Ahmanson UCLA Cardiomyopathy Center, Mechanical Circulatory Support, and Heart Transplant Program, University of California, Los Angeles, David Geffen School of Medicine; Attending Physician, Ronald Reagan UCLA Medical Center

Arnold S Baas, MD, FACC, FACP is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Society of Echocardiography, International Society for Heart and Lung Transplantation

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ronald J Oudiz, MD, FACP, FACC, FCCP Professor of Medicine, University of California, Los Angeles, David Geffen School of Medicine; Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, LA Biomedical Research Institute at Harbor-UCLA Medical Center

Ronald J Oudiz, MD, FACP, FACC, FCCP is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physicians, American Heart Association, American Thoracic Society

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Actelion, Bayer, Gilead, United Therapeutics<br/>Received research grant from: Actelion, Arena, Gilead, GSK, Liquidia, Reata, United Therapeutics<br/>Received income in an amount equal to or greater than $250 from: Actelion, Complexa, Gilead, Medtronic, Reata, United Therapeutics.

Mikhael F El-Chami, MD Associate Professor, Department of Medicine, Division of Cardiology, Section of Electrophysiology, Emory University School of Medicine

Mikhael F El-Chami, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, Heart Rhythm Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Medtronic; Boston Scientific, Biotronik<br/>Received research grants (as part of Multicenter studies) from Medtronic and Boston Scientific.

Russell F Kelly, MD Assistant Professor, Department of Internal Medicine, Rush Medical College; Chairman of Adult Cardiology and Director of the Fellowship Program, Cook County Hospital

Russell F Kelly, MD is a member of the following medical societies: American College of Cardiology

Disclosure: Nothing to disclose.

The authors and editors of Medscape Drugs & Diseases gratefully acknowledge the contributions of previous authors Krishna Malineni, MD, and Peter A McCullough, MD, MPH, FACC, FACP, FCCP, to the development and writing of this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article